X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
humans (16) 16
female (15) 15
male (15) 15
middle aged (12) 12
adult (11) 11
aged (10) 10
carcinoma (9) 9
cancer (8) 8
oncology (8) 8
thyroid cancer (8) 8
young adult (8) 8
mutation (7) 7
child (6) 6
endocrinology & metabolism (6) 6
management (6) 6
mortality (6) 6
retrospective studies (6) 6
thyroid (6) 6
adolescent (5) 5
aged, 80 and over (5) 5
metastasis (5) 5
thyroid neoplasms - pathology (5) 5
abridged index medicus (4) 4
analysis (4) 4
atrial fibrillation (4) 4
child, preschool (4) 4
cohort studies (4) 4
italy (4) 4
kinases (4) 4
mutations (4) 4
overexpression (4) 4
patients (4) 4
recurrence (4) 4
thyroid neoplasms - genetics (4) 4
association (3) 3
braf v600e mutation (3) 3
cardiac & cardiovascular systems (3) 3
endocrine system diseases (3) 3
everolimus (3) 3
immunohistochemistry (3) 3
kaplan-meier estimate (3) 3
life sciences (3) 3
multivariate analysis (3) 3
neoplasm staging (3) 3
phenotype (3) 3
prevalence (3) 3
prognosis (3) 3
proto-oncogene proteins c-ret - genetics (3) 3
ret (3) 3
risk factors (3) 3
stroke (3) 3
treatment outcome (3) 3
tumors (3) 3
adrenal cortex neoplasms - genetics (2) 2
adrenal glands (2) 2
anti-arrhythmia agents - therapeutic use (2) 2
antiarrhythmic drugs (2) 2
apoptosis (2) 2
atrial fibrillation - drug therapy (2) 2
atrial fibrillation - mortality (2) 2
braf (2) 2
braf mutation (2) 2
carcinoma - genetics (2) 2
carcinoma - pathology (2) 2
carcinoma, neuroendocrine (2) 2
carcinoma, papillary (2) 2
care and treatment (2) 2
cell cycle - drug effects (2) 2
cell line, tumor (2) 2
combination (2) 2
complications and side effects (2) 2
disease (2) 2
disease-free survival (2) 2
dronedarone (2) 2
epidemiology (2) 2
flecainide (2) 2
follow-up studies (2) 2
genes (2) 2
genetic aspects (2) 2
genetics & heredity (2) 2
germ-line mutation - genetics (2) 2
germline mutations (2) 2
hematology, oncology and palliative medicine (2) 2
infant (2) 2
medicine & public health (2) 2
medullary-thyroid carcinoma (2) 2
metastases (2) 2
morbidity (2) 2
multiple endocrine neoplasia type 2a - genetics (2) 2
nodules (2) 2
papillary (2) 2
papillary thyroid carcinoma (2) 2
pharmacology & pharmacy (2) 2
pharmacology/toxicology (2) 2
pheochromocytoma (2) 2
proportional hazards models (2) 2
proteins (2) 2
research (2) 2
risk assessment (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 6, pp. 543 - 549
Journal Article
by Castinetti, Frederic, Dr and Qi, Xiao-Ping, Prof and Walz, Martin K, Prof and Maia, Ana Luiza, MD and Sansó, Gabriela, PhD and Peczkowska, Mariola, MD and Hasse-Lazar, Kornelia, MD and Links, Thera P, MD and Dvorakova, Sarka, PhD and Toledo, Rodrigo A, PhD and Mian, Caterina, MD and Bugalho, Maria Joao, PhD and Wohllk, Nelson, MD and Kollyukh, Oleg, MD and Canu, Letizia, MD and Loli, Paola, MD and Bergmann, Simona R, MD and Costa, Josefina Biarnes, MD and Makay, Ozer, MD and Patocs, Attila, MD and Pfeifer, Marija, MD and Shah, Nalini S, MD and Cuny, Thomas, MD and Brauckhoff, Michael, Prof and Bausch, Birke, MD and von Dobschuetz, Ernst, MD and Letizia, Claudio, MD and Barczynski, Marcin, MD and Alevizaki, Maria K, Prof and Czetwertynska, Malgorzata, MD and Ugurlu, M Umit, MD and Valk, Gerlof, MD and Plukker, John T M, Prof and Sartorato, Paola, MD and Siqueira, Debora R, MD and Barontini, Marta, MD and Szperl, Malgorzata, PhD and Jarzab, Barbara, MD and Verbeek, Hans H G, MD and Zelinka, Tomas, MD and Vlcek, Petr, Prof and Toledo, Sergio P A, MD and Coutinho, Flavia L, MD and Mannelli, Massimo, Prof and Recasens, Monica, MD and Demarquet, Lea, MD and Petramala, Luigi, MD and Yaremchuk, Svetlana, MD and Zabolotnyi, Dmitry, MD and Schiavi, Francesca, PhD and Opocher, Giuseppe, MD and Racz, Karoly, MD and Januszewicz, Andrzej, MD and Weryha, Georges, Prof and Henry, Jean-Francois, Prof and Brue, Thierry, Prof and Conte-Devolx, Bernard, Prof and Eng, Charis, Prof and Neumann, Hartmut P H, Prof
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 6, pp. 648 - 655
Journal Article
Human Pathology, ISSN 0046-8177, 2014, Volume 46, Issue 1, pp. 50 - 57
Summary Programmed cell death 4 (PDCD4) is a tumor suppressor gene involved in tumorogenesis. MicroRNA-21 (miR-21) specifically targets PDCD4, and recent... 
Pathology | Immunohistochemistry | PDCD4 | Akt | MiR-21 | Medullary thyroid cancer | RET | CHEMOSENSITIVITY | PROTEIN | TUMOR-SUPPRESSOR PDCD4 | DOWN-REGULATION | CELL-DEATH 4 | PATHOLOGY | CANCER | OVEREXPRESSION | EXPRESSION | Up-Regulation | ras Proteins - genetics | Phosphorylation | Humans | Middle Aged | Apoptosis Regulatory Proteins - analysis | Gene Expression Regulation, Neoplastic | Thyroid Neoplasms - blood | Child, Preschool | Thyroid Neoplasms - chemistry | Male | Young Adult | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Retrospective Studies | Child | Real-Time Polymerase Chain Reaction | RNA-Binding Proteins - analysis | Calcitonin - blood | Genetic Predisposition to Disease | Thyroid Neoplasms - mortality | Signal Transduction | Biomarkers, Tumor - analysis | Down-Regulation | Biomarkers, Tumor - blood | Thyroid Neoplasms - genetics | Phenotype | Ki-67 Antigen - analysis | Carcinoma, Neuroendocrine | Biopsy | Proto-Oncogene Proteins c-akt - analysis | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Mutation | Neoplasm Staging | Proto-Oncogene Proteins c-ret - genetics | Thyroid Neoplasms - pathology | Carcinoma | Sarcoma | Analysis | Thyroid diseases | Cancer | Thyroid cancer | Cell death | Proteins | Studies | Polymerase chain reaction | Genes | Medical prognosis | MicroRNAs | Kinases
Journal Article
EUROPEAN JOURNAL OF ENDOCRINOLOGY, ISSN 0804-4643, 07/2019, Volume 181, Issue 1, pp. 1 - 11
Objective: Follicular-derived thyroid cancers generally have a good prognosis, but in a minority of cases, they have an aggressive behavior and develop distant... 
MANAGEMENT | ENDOCRINOLOGY & METABOLISM | DISTANT METASTASIS | V600E MUTATION | DYNAMIC RISK STRATIFICATION | PAPILLARY | PREVALENCE | CANCER | ASSOCIATION | CARCINOMA | CLINICOPATHOLOGICAL FEATURES | Aggressive behavior | Cytology | Thyroid gland | Metastasis | Multivariate analysis | Patients | Lymph nodes | Nodules | Metastases | Thyroid cancer | Surgery | Mutation | Thyroid
Journal Article
Endocrinology, ISSN 0013-7227, 06/2018, Volume 159, Issue 6, pp. 2348 - 2360
XL184 is a small-molecule kinase inhibitor recently included in first-line systemic therapy for patients with advanced, progressive medullary thyroid cancer... 
RET | METASTASIS | ENDOCRINOLOGY & METABOLISM | MITOCHONDRIAL DYSFUNCTION | PATIENT | MUTATIONS | ANTITUMOR-ACTIVITY | INHIBITOR | COMBINATION | STRESS | CARCINOMA | Secretion | Antibodies | Bioavailability | Kinases | Necrosis | 1-Phosphatidylinositol 3-kinase | Signal transduction | Thyroid cancer | Transfection | Inhibitors | Calcitonin | Cell lines | Curcumin | Synergistic effect | Mutation | Viability | Cancer | Thyroid | Apoptosis
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 09/2017, Volume 102, Issue 9, pp. 3241 - 3250
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, p. e101560
Journal Article
Human Mutation, ISSN 1059-7794, 01/2011, Volume 32, Issue 1, pp. 51 - 58
Journal Article
Journal of Clinical Endocrinology and Metabolism, ISSN 0021-972X, 07/2017, Volume 102, Issue 7, pp. 2620 - 2627
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 08/2010, Volume 163, Issue 2, pp. 301 - 308
Journal Article
Investigational New Drugs, ISSN 0167-6997, 8/2014, Volume 32, Issue 4, pp. 626 - 635
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 01/2016, Volume 101, Issue 1, pp. 264 - 274
Journal Article
European Journal of Cancer, ISSN 0959-8049, 01/2020, Volume 124, pp. 161 - 169
Conservative active surveillance has been proposed for low-risk papillary thyroid microcarcinoma (PTMC), defined as ≤1.0 cm and lacking clinical aggressive... 
Active surveillance | Prognosis | Papillary thyroid microcarcinoma | Risk stratification | BRAF V600E mutation
Journal Article